Skip to search.
 TSX Down 0.16% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Zalicus Inc. (ZLCS)

-NasdaqCM
1.17 0.04(3.31%) Apr 23, 3:59PM EDT
Add to Portfolio
Prev Close:1.21
Open:1.21
Bid:1.08 x 7700
Ask:1.29 x 300
1y Target Est:1.20
Beta:2.05
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.16 - 1.21
52wk Range:0.88 - 8.28
Volume:201,037
Avg Vol (3m):752,202
Market Cap:30.44M
P/E (ttm):N/A
EPS (ttm):-1.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Must Read

Comparison

Symbol% ChgMkt Cap
ZLCSDown 3.31%30.44M
ACT35.45B
NVS209.06B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.16
Quarterly EPS Est (Mar-14) :0.20
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zalicus Inc., a biopharmaceutical company, discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatm... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback